The National Committee for Quality Assurance (NCQA) developed childhood immunization measures as part of the Healthcare Effectiveness Data and Information Set (HEDIS) measures, widely used to assess the reliability of pediatric immunization delivery. Vaccines protect children and adolescents from serious and potentially life-threatening diseases at a time in their lives when they are most vulnerable to disease. Immunizations are essential for disease prevention and are a critical aspect of prevention care for children. Vaccination coverage must be maintained to prevent a resurgence of vaccine-preventable diseases.
HEDIS MEASURES: CIS and IMA Immunization Results: MY2023
Numerator Criteria:
CIS - Assesses the percentage of children 2 years of age who had (4) diphtheria, tetanus and acellular pertussis (DTaP); (3) polio (IPV); (1) measles, mumps and rubella (MMR); (3) haemophilus influenza type B (HiB); (3) hepatitis B (HepB), (1) chickenpox (VZV); (4) pneumococcal conjugate (PCV); (1) hepatitis A (HepA); (2 or 3) rotavirus (RV); and (2) influenza (flu) vaccines on or before their second birthday.
IMA - Assesses adolescents 13 years of age who had (1) dose of meningococcal vaccine, (1) Tdap vaccine and the complete (2 dose or 3 dose) human papillomavirus vaccine series by their 13th birthday.
CHILDHOOD IMMUNIZATIONS
(CIS) – COMBO #10 |
WHA
MY2021 |
WHA
MY2022 |
WHA
MY2023 |
WHA NCQA
Benchmark |
NCQA
90%tile |
---|---|---|---|---|---|
Childhood Immunizations
|
57.18
|
58.31
|
50.12
|
33rd
|
67.99
|
ADOLESCENT IMMUNIZATIONS (IMA) – COMBO #2
|
WHA MY2021
|
WHA MY2022
|
WHA MY2023
|
WHA NCQA
Benchmark MY2023 |
NCQA 90%tile
|
---|---|---|---|---|---|
Meningococcal
|
78.35
|
79.32
|
75.67
|
10th
|
93.81
|
Tdap
|
89.78
|
91.73
|
91.73
|
50th
|
95.38
|
Combo 2, with HPV
|
41,36
|
36.98
|
37.23
|
50th
|
48.85
|
HPV (Human papillomavirus)
|
43.07
|
39.66
|
38.69
|
50th
|
49.88
|
What can YOU do to ensure your patients get fully vaccinated? The CDC encourages healthcare providers to consider immunization quality improvement projects that include bringing about measurable increases in HPV vaccination rates, particularly co-administration rates with other adolescent vaccines at the 11-12-year-old visit and reducing disparities in immunization rates, whether associated with race, ethnicity, lack of insurance coverage or any other factor resulting in less-than-optimal rates, along with other improvements.
Strongly recommend adolescent vaccines to parents of your 11 through 18-year-old patients and educate parents about diseases that can be prevented by vaccines. Parents trust your opinion more than anyone else’s when it comes to immunizations. Ask about vaccination status during sick visits and sports physicals. Use patient reminder and recall systems such as automated postcards, phone calls and text messages as these are effective tools for increasing office visits. Implement standing orders policies so that patients can receive vaccines without a physician examination or individual physician order. Direct parents who want more information on vaccines and vaccine-preventable diseases to visit the CDC website at cdc.gov/vaccines/teens or to call 800.CDC.INFO.
Current Immunization Schedules: Visit the Provider Section of WHA’s website to access the current Immunization Schedules at mywha.org/PHGS.
Immunization Catch-up Schedule: To help avoid instances of a member receiving the 4th DTaP or 3rd Hep-B after the member’s second birthday, WHA has posted the CDC’s Childhood Immunization catch-up schedule.
To access the catch-up schedule directly from the CDC, go to:
Centers for Disease Control and Prevention. (2024, June 27).
Catch-up immunization schedule. Centers for Disease Control and Prevention.
Retrieved August 39, 2024, from https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age.html
Last review date: September 13, 2024